交易中 09-23 10:45:48 美东时间
-1.125
-10.56%
U.S. stock futures were slightly higher this morning, with the Dow futures gaining around 0.1% on Wednesday. Shares of InnovAge Holding Corp (NASDAQ:INNV) fell sharply in pre-market trading after the company announced the pricing of a secondary offering of its common stock by selling stockholders. I...
今天 20:03
InnovAge Holding Corp. (NASDAQ:INNV) shares fell 9.43% to $9.65 in after-hours trading Tuesday after the company announced the pricing of a secondary offering of its common stock by selling stockholders. InnovAge is a healthcare company providing comprehensive programs to frail, predominantly dual-e...
今天 14:48
InnovAge Holding (INNV) said on Tuesday Apax Partners- and Welsh Carson-affiliated funds are offering 10M existing shares in a secondary offering. The selling stockholders may grant underwriters a 30-...
今天 04:11
InnovAge Holding Corp. (“InnovAge” or the “Company”) (NASDAQ:INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced the launch of an underwritten public ...
今天 04:04
Innovage Holding Corp. (($INNV)) has held its Q4 earnings call. Read on for the...
09-16 08:31
今日重点评级关注:富国银行:维持Pyxis Oncology"超配"评级,目标价从12美元升至19美元;Oppenheimer:维持Opus Genetics"跑赢大市"评级,目标价从10美元升至20美元
09-10 15:00
Keybanc analyst Matthew Gillmor maintains InnovAge Holding (NASDAQ:INNV) with a Overweight and raises the price target from $13 to $14.
09-09 20:42
InnovAge Holding Corp. (NASDAQ:INNV) shares climbed 10.25% to $11.60 in after-hours trading on Tuesday after the company announced fourth-quarter results, where revenue of $261.95 million surpassed the analyst estimate of $238.28 million by 9.93%. The Denver-based senior healthcare provider announce...
09-09 16:05
InnovAge Holding (NASDAQ:INNV) sees FY2027 sales of $1.050 billion-$1.085 billion vs $1.038 billion analyst estimate.
09-09 04:08
InnovAge Holding (NASDAQ:INNV) reported quarterly earnings of $0.06 per share which missed the analyst consensus estimate of $0.07 by 14.29 percent. This is a 700 percent increase over losses of $(0.01) per share from the same period last year. The company reported quarterly sales of $261.951 millio...
09-09 04:05